Skip to main content

Table 2 Diagnosis and operative data

From: Mesh-reinforced pancreaticojejunostomy versus conventional pancreaticojejunostomy after pancreaticoduodenectomy: a retrospective study of 126 patients

 

mPJ group (n = 65)

cPJ group (n = 61)

p value

Pathology (%)

  

0.839

 Pancreatic cancer

18 (28)

13 (21)

 

 Bile duct cancer

22 (34)

24 (39)

 

 Ampullary cancer

8 (12)

6 (10)

 

 Duodenum cancer

12 (18)

11 (18)

 

 Other

5 (8)

7 (11)

 

Pancreatic texture (%)

  

0.765

 Hard

39 (60)

35 (57)

 

 Soft

26 (40)

26 (43)

 

Main pancreatic duct (%)

  

0.975

 3 mm

51 (78)

48 (79)

 

 > 3 mm

14 (22)

13 (21)

 

Operative time (min)

359 ± 69

351 ± 63

0.487

Blood loss (mL)

606 ± 218

626 ± 224

0.818

  1. mPJ mesh-reinforced pancreaticojejunostomy, cPJ conventional pancreaticojejunostomy